FCCC LOGO Faculty Publications
Mohler JL , Kantoff PW , Armstrong AJ , Bahnson RR , Cohen M , D'Amico AV , Eastham JA , Enke CA , Farrington TA , Higano CS , Horwitz EM , Kane CJ , Kawachi MH , Kuettel M , Kuzel TM , Lee RJ , Malcolm AW , Miller D , Plimack ER , Pow-Sang JM , Raben D , Richey S , Roach M 3rd , Rohren E , Rosenfeld S , Schaeffer E , Small EJ , Sonpavde G , Srinivas S , Stein C , Strope SA , Tward J , Shead DA , Ho M , National Comprehensive Cancer Network
Prostate cancer, version 2.2014
J Natl Compr Canc Netw. 2014 May;12(5) :686-718
Back to previous list
Abstract
Prostate cancer has surpassed lung cancer as the most common cancer in men in the United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management of patients with prostate cancer based on clinical evidence and expert consensus. NCCN Panel guidance on treatment decisions for patients with localized disease is represented in this version. Significant updates for early disease include distinction between active surveillance and observation, a new section on principles of imaging, and revisions to radiation recommendations. The full version of these guidelines, including treatment of patients with advanced disease, can be found online at the NCCN website.
Notes
Mohler, James L Kantoff, Philip W Armstrong, Andrew J Bahnson, Robert R Cohen, Michael D'Amico, Anthony Victor Eastham, James A Enke, Charles A Farrington, Thomas A Higano, Celestia S Horwitz, Eric Mark Kane, Christopher J Kawachi, Mark H Kuettel, Michael Kuzel, Timothy M Lee, Richard J Malcolm, Arnold W Miller, David Plimack, Elizabeth R Pow-Sang, Julio M Raben, David Richey, Sylvia Roach, Mack 3rd Rohren, Eric Rosenfeld, Stan Schaeffer, Edward Small, Eric J Sonpavde, Guru Srinivas, Sandy Stein, Cy Strope, Seth A Tward, Jonathan Shead, Dorothy A Ho, Maria eng P30 CA008748/CA/NCI NIH HHS/ Practice Guideline J Natl Compr Canc Netw. 2014 May;12(5):686-718. doi: 10.6004/jnccn.2014.0072.